"Teva Pharmaceuticals, a leading constructor of generic drugs, has been aggressively lobbying chamber to scrap provisions in the health care bills it claims would shut it out of the biologic drug market for too long," Roll Call reports. Lobbyists for the biologics makers have charged, however, that Teva is hypocritical because it is fighting to restrict generic elongation of its own brand-name product.

More: - Brought to my attention by